American Well's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of American Well (AMWL) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: American Well vs Its Competitors
- TTM: Trailing 12-month revenue of 219M vs 286,369M combined for tracked competitors (0.1% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-4.7% annualized vs trailing 12 months), vs holding steady (+1.5%) for its tracked peer group.
- Growth: American Well generated -26.6% revenue growth year over year in Q2 2026, vs 6.6% for its tracked competitors combined.
- Profitability: Its -18.5% net margin compares with 2.4% for the peer group.
- Scale: American Well ranks #91 of 168 companies by market capitalization in the Professional Services industry, holding 0.0% of industry market cap.
- Peer revenue share: American Well accounted for 0.1% of combined revenue among its tracked peer group, down from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.39M compares with $3.42M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
AMWL Sales vs. its Competitors, Q2 2026
American Well reported revenue contraction of 26.59 % year on year in Q2 2026, below its competitors' combined revenue growth of 6.63 %.
With a net margin of -18.49 %, American Well reported lower profitability than its competitors (2.40 %).
American Well generated 0.07 % of the combined sales of its peer group, down from 0.10 % a year earlier.
American Well vs. its Competitors, Q2 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across American Well and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| American Well Corporation | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (12) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (7) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (3) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across American Well's competitor groups requires a Commercial License.
For context: the Professional Services industry grew revenue 6.8% year over year, combined, vs -26.6% for American Well. American Well's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.
American Well's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| American Well Corporation | No | No | No | No |
| Competitors combined (6) | ||||
| High-Confidence Competitors (13) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 7) | 0.00 % (0 of 8) | 0.00 % (0 of 8) | 20.00 % (1 of 5) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
AMWL Stock Performance relative to its Competitors
AMWL Stock Performance relative to High-Confidence Competitors
AMWL Stock Performance relative to Similar-Size Competitors
AMWL Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | U S Physical Therapy Inc | 282.9% | Outperformed |
| 2 | The Cigna Group | 282.9% | Outperformed |
| 3 | Teladoc Health Inc | 282.9% | Outperformed |
| 4 | Accolade Inc | 282.9% | Outperformed |
| 5 | Doximity Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for American Well's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
American Well's Comment on Competition and Industry Peers
Publicly Traded Peers of American Well Corporation
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| American Well Corporation | 225.27 | 218.53 |
| The Cigna Group | 71,752.79 | 282,382.00 |
| Doximity Inc | 5,008.63 | 656.04 |
| U S Physical Therapy Inc | 1,297.38 | 812.20 |
| Teladoc Health Inc | 1,066.24 | 2,489.48 |
| Accolade Inc | 566.14 | 446.72 |
| SUBTOTAL | 80,110.85 | 287,033.92 |
Sign in to see all competitors of American Well Corporation.
Sources: American Well Corporation's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on American Well Corporation versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
American Well's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Doximity | Named by the company | 85% |
| Cue Health Inc | Named by the company | 85% |
| Teladoc | Named by the company | 85% |
| Named by the company | 85% | |
| Memora Health | Named by the company | 85% |
| Twistle | Named by the company | 85% |
| Vsee Health Inc | Named by the company | 85% |
| Ableto | Named by the company | 85% |
| athenahealth | Named by the company | 85% |
| Included Health | Named by the company | 85% |
| Oracle Health | Named by the company | 85% |
| Apple | Named by the company | 85% |
| Caregility | Named by the company | 85% |
| GetWell Loop | Named by the company | 85% |
| Microsoft | Named by the company | 85% |
| Verizon | Named by the company | 85% |
| Allscripts | Named by the company | 85% |
| Avasure | Named by the company | 85% |
| Epic | Named by the company | 85% |
| MDLive | Named by the company | 85% |
| Talkspace Inc | Named by the company | 85% |
| Array | Named by the company | 85% |
| Doctor On Demand | Named by the company | 85% |
| Headspace | Named by the company | 85% |
| Neuroflow | Named by the company | 85% |
| Zoom | Named by the company | 85% |
| Amazon | Named by the company | 85% |
| Care.AI | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for American Well's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
American Well's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| The Cigna Group | Evernorth 85.32 % |
| U S Physical Therapy Inc | Physical Therapy Operations 85.19 % |
| Teladoc Health Inc | Teladoc Health Integrated Care 64.42 % |
| Nakamoto Inc | Media and Information Services 0.00 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
American Well's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| American Well Corporation | 225 | 388,835 | -137,021 |
| The Cigna Group | 71,753 | 4,171,078 | 103,146 |
| Doximity Inc | 5,009 | 790,404 | 201,260 |
| U S Physical Therapy Inc | 1,297 | 111,352 | 6,837 |
| Teladoc Health Inc | 1,066 | 444,550 | -31,678 |
| Accolade Inc | 566 | 186,133 | -75,124 |
| PEERS TOTAL | 79,886 | 3,418,987 | 76,550 |
Sign in to see all peers for American Well Corporation.
American Well's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Teladoc Health Inc | United States 80.07 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
American Well's Position in Industry Market Structure
Market-capitalization share and concentration across all 155 companies in American Well's industry classification, broader than the peer set above. Market cap in millions of $.American Well ranks #91 of 155 companies by market capitalization in its industry, holding 0.01 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,029, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Visa Inc | 705,447 | 22.66 % |
| 2 | Mastercard Incorporated | 500,352 | 16.07 % |
| 3 | Repay Holdings Corporation | 308,989 | 9.93 % |
| 4 | Alibaba Group Holding Limited | 254,590 | 8.18 % |
| 5 | Uber Technologies Inc | 1,234 | 5.2% |
| 6 | Accenture Plc | 1,234 | 5.2% |
| 7 | Pdd Holdings inc | 1,234 | 5.2% |
| 8 | Orix Corporation | 1,234 | 5.2% |
| 9 | Mercadolibre Inc | 1,234 | 5.2% |
| 10 | Uxin Limited | 1,234 | 5.2% |
| 91 | American Well Corporation | 227 | 0.01 % |
Market cap and industry share for the rest of American Well's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
American Well's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 86 | Trueblue Inc | 282 | 48.56 % |
| 87 | I3 Verticals Inc | 279 | -54.83 % |
| 88 | Alight Inc | 273 | 237.13 % |
| 89 | Hirequest Inc | 266 | 94.65 % |
| 90 | Conduent Inc | 1,234 | 12.3% |
| 91 | American Well Corporation | 227 | 121.24 % |
| 92 | Forrester Research Inc | 1,234 | 12.3% |
| 93 | Troops Inc | 1,234 | 12.3% |
| 94 | Dhi Group Inc | 1,234 | 12.3% |
| 95 | Currenc Group Inc | 1,234 | 12.3% |
| 96 | Melar Acquisition Corp I | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of American Well's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
American Well's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Professional Services industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (230 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 51.88 % | 47.17 % (avg) | +4.7 pp |
| Operating Margin | -37.28 % | industry median | -41.5 pp |
| EBITDA Margin | -14.05 % | 5.74 % (avg) | -19.8 pp |
| Capital Intensity (Capex / Revenue) | - | 4.25 % (avg) | - |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
American Well's Valuation vs Competitive Position
Valuation multiples vs the Professional Services industry average (230 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 25.6x | - |
| EV / EBITDA | - | 15.4x | - |
| P/B | 0.6x | 3.7x | -3.1x |
| Return on Equity | -31.13 % | industry aggregate | -55.22 % |
| Return on Invested Capital | -15.94 % | 5.25 % (avg) | -21.19 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
American Well's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue Growth | - | - | 9.65 % | -6.55 % | -1.81 % | -1.98 % |
| Operating Margin | - | -70.87 % | -99.52 % | -267.19 % | -85.52 % | -42.22 % |
| Return on Invested Capital | - | -7.07 % | -11.88 % | -56.99 % | -28.66 % | -18.30 % |
| P/E | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
American Well's Strategic Group Map
Every company in American Well's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. American Well is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
American Well's BCG Growth-Share Matrix
Relative market share (vs American Well's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
American Well falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 5.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
American Well's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,029 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See American Well's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See American Well's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
American Well's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
American Well falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
American Well's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Outperforming the U.S.A. 500 over the trailing 12 months.
Weaknesses
- Operating margin 41.5 points below the industry median.
- Return on equity 55.2 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-4.7% annualized vs trailing 12 months).
- Low relative market share vs the industry leader (0.00x).
Opportunities
No rule matched.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
American Well's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| American Well Corporation | 2.27 | 3.11 | - |
| The Cigna Group | 0.12 | 0.82 | 0.76 |
| Doximity Inc | 1.45 | 6.71 | - |
| U S Physical Therapy Inc | 0.25 | 1.16 | 0.39 |
| Teladoc Health Inc | 1.17 | 1.73 | 0.73 |
| Accolade Inc | 1.79 | 2.70 | 0.52 |
Sign in to see all peers for American Well Corporation.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
American Well's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| American Well Corporation | Q2 2026 | -26.6 % | - |
| The Cigna Group | Q2 2026 | +6.7 % | +22.4 % |
| Doximity Inc | Q2 2026 | +7.9 % | -54.4 % |
| U S Physical Therapy Inc | Q2 2026 | +8.5 % | -15.9 % |
| Teladoc Health Inc | Q2 2026 | -4.0 % | - |
| Accolade Inc | Q4 2024 | +5.7 % | - |
| PEERS TOTAL | +6.6 % | +5.5 % |
Sign in to see all peers for American Well Corporation.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
American Well's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| American Well Corporation | Q2 2026 | -21.4 % | - |
| The Cigna Group | Q2 2026 | +6.4 % | - |
| Doximity Inc | Q2 2026 | +57.9 % | +21.3 % |
| U S Physical Therapy Inc | Q2 2026 | +10.5 % | +65.0 % |
| Teladoc Health Inc | Q2 2026 | +0.2 % | -30.4 % |
| Accolade Inc | Q4 2024 | +7.4 % | -76.5 % |
Sign in to see all peers for American Well Corporation.
American Well's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| American Well Corporation | - | - | - |
| The Cigna Group | 4.46% | 6.88% | 16.50% |
| Doximity Inc | 14.13% | 16.19% | 16.52% |
| U S Physical Therapy Inc | 4.08% | 3.91% | 10.50% |
| Teladoc Health Inc | - | - | - |
| Accolade Inc | - | - | - |
Sign in to see all peers for American Well Corporation.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
American Well's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| American Well Corporation | - | 1.03 |
| The Cigna Group | 11.27 | 0.25 |
| Doximity Inc | 30.84 | 7.63 |
| U S Physical Therapy Inc | 97.66 | 1.60 |
| Teladoc Health Inc | - | 0.43 |
| Accolade Inc | - | 1.27 |
| PEERS AVERAGE | 12.63 | 0.28 |
Sign in to see all peers for American Well Corporation.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.